Mehdi Soleymani Goloujeh, PhD, MSc

Title(s)Postdoctoral Scholar, Diabetes Center
SchoolSchool of Medicine
Address513 Parnassus Avenue, HSW, #1102
San Francisco CA 94143
Phone415-514-2111
PronounsHe/Him/His
ORCID ORCID Icon0000-0002-6478-3951 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San Francisco, SF, USAPostdoctoral ScholarOngoingType 1 Diabetes
    Royan Institute, Tehran, IranPh.D.06/2023Applied Cell Sciences
    Tabriz University of Medical Sciences, Tabriz, IranM.Sc.10/2016Medical Nanotechnology
    Urmia University of Medical Sciences, Urmia, IranB.Sc.07/2013Radiology Technology

    Collapse Overview 
    Collapse Overview
    Mehdi Soleymani-Goloujeh, Ph.D. is a Postdoctoral Scholar in the Parent and Tang labs at UCSF Diabetes Center. He obtained his Ph.D. in Applied Cell Sciences from the Royan Institute for Stem Cell Biology and Technology, Tehran, Iran. He joined the laboratories of Dr. Qizhi Tang and Dr. Audrey Parent in July 2023. His current research is on human pluripotent stem cell-derived β-cells and immunomodulation in Type 1 Diabetes (T1D). His research interests include stem cell biology, cell therapy, regenerative medicine, diabetes, and immunology. He has published several papers in these fields and served as a reviewer for several scientific journals. He is committed to discovering novel T1D treatments by leveraging stem cells and immunomodulation.

    Collapse Featured Content 
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Impact of microRNA variants on PI3K/AKT signaling in triple-negative breast cancer: comprehensive review. Med Oncol. 2024 Aug 09; 41(9):222. Mehrtabar E, Khalaji A, Pandeh M, Farhoudian A, Shafiee N, Shafiee A, Ojaghlou F, Mahdavi P, Soleymani-Goloujeh M. PMID: 39120634.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    2. Don't eat me/eat me signals as a novel strategy in cancer immunotherapy. Heliyon. 2023 Oct; 9(10):e20507. Khalaji A, Yancheshmeh FB, Farham F, Khorram A, Sheshbolouki S, Zokaei M, Vatankhah F, Soleymani-Goloujeh M. PMID: 37822610; PMCID: PMC10562801.
      View in: PubMed   Mentions: 4  
    3. Preconditioning with IFN-γgamma and LPS improves the immunomodulatory potential of bone marrow-derived clonal mesenchymal stem cells. 2023. Mehdi Soleymani-Goloujeh, Faezeh Shekari, Seyedeh-Nafiseh Hassani, Ensiyeh Hajizadeh-Saffar . View Publication.
    4. Role of cancer stem cell-derived extracellular vesicles in cancer progression and metastasis. Pathol Res Pract. 2023 Jul; 247:154558. Naghibi AF, Daneshdoust D, Taha SR, Abedi S, Dehdezi PA, Zadeh MS, Dokoohaki F, Soleymani-Goloujeh M. PMID: 37245267.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    5. Advanced Nanotechnology Approaches as Emerging Tools in Cellular-Based Technologies. Adv Exp Med Biol. 2023; 1409:127-144. Soleymani-Goloujeh M, Hosseini S, Baghaban Eslaminejad M. PMID: 35816248.
      View in: PubMed   Mentions:    Fields:    
    6. Epigenetics and its therapeutic potential in colorectal cancer. Epigenomics. 2022 06; 14(11):683-697. Oryani MA, Tavasoli A, Ghalavand MA, Ashtiani RZ, Rezaee A, Mahmoudi R, Golvari H, Owrangi S, Soleymani-Goloujeh M. PMID: 35473313.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    7. Effects of self-assembled cell-penetrating peptides and their nano-complexes on ABCB1 expression and activity. Iran J Basic Med Sci. 2021 Mar; 24(3):383-390. Niazi M, Zakeri-Milani P, Soleymani-Goloujeh M, Mohammadi A, Sarfraz M, Löbenberg R, Najafi-Hajivar S, Shahbazi-Mojarrad J, Farshbaf M, Valizadeh H. PMID: 33995950; PMCID: PMC8087847.
      View in: PubMed   Mentions: 1  
    8. Cytotoxicity and Immunogenicity Evaluation of Synthetic Cell-penetrating Peptides for Methotrexate Delivery. Iran J Pharm Res. 2021; 20(3):506-515. Zakeri-Milani P, Najafi-Hajivar S, Sarfraz M, Nokhodchi A, Mohammadi H, Montazersaheb S, Niazi M, Hemmatzadeh M, Soleymani-Goloujeh M, Baradaran B, Shahbazi Mojarrad J, Farshbaf M, Gholikhani T, Valizadeh H. PMID: 34904004; PMCID: PMC8653662.
      View in: PubMed   Mentions: 3  
    9. Ethics of research on stem cells and regenerative medicine: ethical guidelines in the Islamic Republic of Iran. Stem Cell Res Ther. 2020 09 14; 11(1):396. Afshar L, Aghayan HR, Sadighi J, Arjmand B, Hashemi SM, Basiri M, Samani RO, Ashtiani MK, Azin SA, Hajizadeh-Saffar E, Gooshki ES, Hamidieh AA, Rezania Moallem MR, Azin SM, Shariatinasab S, Soleymani-Goloujeh M, Baharvand H. PMID: 32928295; PMCID: PMC7489032.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    10. Extracellular Vesicles in Regenerative Medicine, a Brief Review. 2019; 2(2):118-126. Soleymani-Goloujeh M, Saberi S, Shekari F. View Publication.
    11. Effects of N-terminal and C-terminal modification on cytotoxicity and cellular uptake of amphiphilic cell penetrating peptides. Artif Cells Nanomed Biotechnol. 2018; 46(sup1):91-103. Soleymani-Goloujeh M, Nokhodchi A, Niazi M, Najafi-Hajivar S, Shahbazi-Mojarrad J, Zarghami N, Zakeri-Milani P, Mohammadi A, Karimi M, Valizadeh H. PMID: 29258339.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    12. Overview on experimental models of interactions between nanoparticles and the immune system. Biomed Pharmacother. 2016 Oct; 83:1365-1378. Najafi-Hajivar S, Zakeri-Milani P, Mohammadi H, Niazi M, Soleymani-Goloujeh M, Baradaran B, Valizadeh H. PMID: 27580456.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimals
    13. Nano-based strategies to overcome p-glycoprotein-mediated drug resistance. Expert Opin Drug Metab Toxicol. 2016 Sep; 12(9):1021-33. Niazi M, Zakeri-Milani P, Najafi Hajivar S, Soleymani Goloujeh M, Ghobakhlou N, Shahbazi Mojarrad J, Valizadeh H. PMID: 27267126.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    14. The Systematic Review of Proteins Digestion and New Strategies for Delivery of Small Peptides. 2016. Sina Vahdatpour, Aniseh Pourrasmi-Mamaghani, Mehdi Soleymani- Goloujeh, Naser Maheri-Sis, Hamid Mahmoodpour, Tohid Vahdatpour. View Publication.
    15. Current methods for synthesis of magnetic nanoparticles. Artif Cells Nanomed Biotechnol. 2016; 44(2):722-34. Majidi S, Sehrig FZ, Farkhani SM, Goloujeh MS, Akbarzadeh A. PMID: 25435409.
      View in: PubMed   Mentions: 55     Fields:    
    Mehdi's Networks
    Concepts (53)
    Derived automatically from this person's publications.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-5-g94c7c43e on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.